Home Patent Forecast® Sectors Log In   Contact  
How it works Patent Forecast® Sectors Insights
Menu

Predictive test for melanoma IL2 therapy

AI Biotech/Diagnostics: Other Innovation Patent Forecast®

January 23, 2019

Biodesix, located in Boulder CO, is developing a way to predict whether a melanoma patient is likely to benefit from high dose interleukin-2 (IL2) therapy in treatment of cancer. It uses mass spectrometry data obtained from a blood-based sample of the patient and uses classifiers to guide treatment of the melanoma patient.


Relevant Patent Documents

Application US20190018929  

Article Source Link

www.biodesix.com


View Patent Forecast®

Artificial intelligence and human health don’t stop with our general diagnostics, cardiology, neurology, and activity sectors. This sector covers AI/ML-centric advancements in auditory, dental, GI/hepatic, circulatory, immune, musculoskeletal, ocular, reproductive, respiratory, dermatological, urinary, rectal, and spectrometry related biotech.

AI Biotech/Diagnostics: Other Innovation   Patent Forecast®

View Patent Forecast® Top Corporations News and Insights Data Visualization

Artificial intelligence and human health don’t stop with our general diagnostics, cardiology, neurology, and activity sectors. This sector covers AI/ML-centric advancements in auditory, dental, GI/hepatic, circulatory, immune, musculoskeletal, ocular, reproductive, respiratory, dermatological, urinary, rectal, and spectrometry related biotech.



301